MapLight Therapeutics, Inc. (MPLT)
13.39
+0.42
(+3.24%)
USD |
NASDAQ |
Sep 01, 16:00
13.39
0.00 (0.00%)
After-Hours: 20:00
MapLight Therapeutics Cash from Investing (Quarterly) : 60.70M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 60.70M |
| March 31, 2026 | 67.01M |
| December 31, 2025 | -242.55M |
| September 30, 2025 | -135.59M |
| June 30, 2025 | 17.43M |
| Date | Value |
|---|---|
| March 31, 2025 | 37.50M |
| June 30, 2024 | -121.82M |
| March 31, 2024 | -0.002M |
| March 31, 2023 | -0.077M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Evommune, Inc. | 31.29M |
| Sarepta Therapeutics, Inc. | -93.37M |
| Cullinan Therapeutics, Inc. | 40.68M |
| Mineralys Therapeutics, Inc. | -185.22M |
| Apogee Therapeutics, Inc. | -381.86M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -44.87M |
| Cash from Financing (Quarterly) | 0.092M |
| Free Cash Flow | -175.12M |
| Free Cash Flow Per Share (Quarterly) | -0.9881 |
| Free Cash Flow to Equity (Quarterly) | -41.29M |
| Free Cash Flow to Firm (Quarterly) | -44.89M |
| Free Cash Flow Yield | -29.06% |